Risk factors for in-hospital mortality in cirrhotic patients with oesophageal variceal bleeding

European Journal of Gastroenterology and Hepatology

Volumn 24, Issue 5, 2012, Pages 551-557

  Cerqueira, Rute Maria ^a   Andrade, Luis ^b   Correia, Manuel Rodriguez ^a   Fernandes, Carolina Duesca ^a   Manso, Maria Conceição ^c,d  

^a Hospital So Sebastio   (Portugal)

^b Surgery S Sebastião Hospital   (Portugal)

^c UNIVERSIDADE FERNANDO PESSOA   (Portugal)

^d UNIVERSITY OF PORTO   (Portugal)

Author keywords

Child Turcotte Pugh score; Model for End Stage Liver Disease score; mortality; oesophageal variceal bleeding

Indexed keywords

CIPROFLOXACIN; HEMOGLOBIN; NORFLOXACIN; OCTREOTIDE; TERLIPRESSIN;

ADULT; ARTICLE; BLOOD TRANSFUSION; ERYTHROCYTE CONCENTRATE; ESOPHAGOSCOPY; ESOPHAGUS HEMORRHAGE; FEMALE; HEMOGLOBIN BLOOD LEVEL; HIGH RISK PATIENT; HOSPITAL ADMISSION; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; THROMBOCYTE COUNT; TREATMENT DURATION;

ADULT; AGED; AGED, 80 AND OVER; ERYTHROCYTE TRANSFUSION; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; GASTROINTESTINAL AGENTS; GASTROINTESTINAL HEMORRHAGE; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; LIVER CIRRHOSIS; LYPRESSIN; MALE; MIDDLE AGED; OCTREOTIDE; PLATELET COUNT; PORTUGAL; RISK FACTORS; SEVERITY OF ILLNESS INDEX; VASOCONSTRICTOR AGENTS;

EID: 84859419667     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0b013e3283510448     Document Type: Article

References (18)

1. D'Amico G, Pagliaro L, Bosch J. Pharmacological treatment of portal hypertensive: an evidence based approach. Semin Liver Dis 1999; 19:475-505. (Pubitemid 30032646)
2. Chalasani N, Kahi C, Francois F, Pinto A, Marathe A, Bini EJ, et al. Improved patient survival after acute variceal bleeding: a multicenter, cohort study. Am J Gastroenterol 2003; 98:653-659. (Pubitemid 36348540)
3. D'Amico G, De Franchis R. A Cooperative Group. Upper digestive bleeding in cirrhosis: post-therapeutic outcome and prognostic indicators. Hepatology 2003; 38:599-612. (Pubitemid 37052147)
4. Carbonell N, Pauwels A, Sefarty L, Fourdan O, Levy VG, Poupon R. Improved survival after variceal hemorrhage in patients with cirrhosis over the past two decades. Hepatology 2004; 40:652-659. (Pubitemid 39265587)
5. McCormick PA, O'Keefe C. Improving prognosis following a first variceal hemorrhage over four decades. Gut 2001; 49:682-685. (Pubitemid 32989206)
6. El- Serag HB, Everhart JE. Improved survival after variceal hemorrhage over an 11 year period in the Department of Veterans Affairs. Am J Gastroenterol 2000; 95:3566-3573.
7. Del Olmo JA, Pena A, Serra MA, Wassel AH, Benages A, Rodrigo JM. Predictors of morbidity and mortality after the first episode of upper gastrointestinal bleeding in liver cirrhosis. J Hepatol 2000; 32:19-24. (Pubitemid 30039442)
8. Burroughs AK. The natural history of varices. J Hepatol 1993; 17 (Suppl 2): S10-S13. (Pubitemid 23100209)
9. Bosch J, Garcia-Pagan JC. Prevention of variceal rebleeding. Lancet 2003; 361:952-954. (Pubitemid 36332114)
10. Amitrano L, Guardascione MA, Bennato R, Manguso F, Balzano A. MELD score and hepatocellular carcinoma identify patients at different risk of shortterm mortality among cirrhotics bleeding from esophageal varices. J Hepatol 2005; 42:820-825. (Pubitemid 40693198)
11. Bambha K, Kim WR, Pedersen R, Bida JP, Kremers WK, Kamath PS. Predictors of early rebleeding and mortality after acute variceal bleeding in patients with cirrhosis. Gut 2008; 57:814-820. (Pubitemid 351716977)
12. Chen WT, Lin CY, Sheen IS, Huang CW, Lin NT, Lin CJ, et al. MELD score can predict early mortality in patients with rebleeding after band ligation for variceal bleeding. World J Gastroenterol 2011; 17:2120-2125.
13. Kamath PS,Wiesner RH, Malinchoc M, KremersW, Therneau TM, Kisberg CL, et al. A model to predict survival in patients with end stage liver disease. Hepatology 2001; 33:464-470. (Pubitemid 32119037)
14. Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, et al. The model for end stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003; 124:91-96. (Pubitemid 36055342)
15. Chalasani N, Kahi C, Francois F, Pinto A, Marathe A, Bini EJ, et al. Model for end stage liver disease (MELD) for predicting mortality in patients with acute variceal bleeding. Hepatology 2002; 35:1282-1284. (Pubitemid 34454029)
16. De Franchis R. Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol 2000; 33:846-852.
17. Garcia-Tsao G, D'Amico G, Abraldes JG. Predictive models in portal hypertension. In: De Franchis R, editor. Portal Hypertension Proceedings of the Fourth Baveno International Consensus Workshop on methodology of diagnosis and treatment. UK: Blackwell Publishing Ltd; 2006. pp. 47-100.
18. Bosch J, Berzigotti A, Garcia-Pagan JC, Abraldes JG. The management of portal hypertension: rational basis, available treatments and future options. J Hepatol 2008; 48 (Suppl 1):S68-S92.